Company: REVB
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034584
Chunk: 52

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 16
Chunk 52
---
 Agent Common Stock Warrants (exercise price of $55,272.00 per share)

        22

        22

        Class B Common Stock Warrants (exercise price of $10,080.00 per share)

        497

        497

        Class B Placement Agent Common Stock Warrants (exercise price of $12,600.00 per share)

        35

        35

        Class C Common Stock Warrants (exercise price of $16.00 per share)

        485

        1,014

        Class D Common Stock Warrants (exercise price of $3.849 per share)

        5,060

        —

        Class E Common Stock Warrants (exercise price of $16.00 per share)

        64,506

        —

        Class F Common Stock Warrants (alternative cashless exercise)

        508,006

        —

        Class G Common Stock Warrants (exercise price of $3.7596 per share)

        381,004

        —

        Rollover Warrants (exercise price of $45,070.73 per share)

        7

        7

        Rollover RSU awards outstanding

        3

        3

        Stock options outstanding (minimum exercise price $571.20)

        64

        64

        Shares reserved for issuance

        960,469

        2,422

        Shares available for future stock grants under the 2021 Equity Incentive Plan

        10,142

        1,288

        Total common stock reserved for issuance

        970,611

        3,710

9. Stock-Based Compensation2021 Equity Incentive PlanIn January 2022, the Board of Directors and the Company’s stockholders adopted the 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan is administered by the Board of Directors. Vesting periods and other restrictions for grants under the 2021 Plan are determined at the discretion of the Board of Directors. Grants to employees, officers, directors, advisors, and consultants of the Company typically vest over one to four years. In addition, the number of shares of stock available for issuance under the 2021 Plan will be automatically increased each January 1, and began on January 1, 2022, by 10% of the aggregate number of outstanding shares of our common stock